Columnar-lined esophagus without intestinal metaplasia has no proven risk of adenocarcinoma

American Journal of Surgical Pathology

Volumn 36, Issue 1, 2012, Pages 1-7

  Chandrasoma, Parakrama ^a   Wijetunge, Sulochana ^a   Demeester, Steven ^b   Ma, Yanling ^a   Hagen, Jeffrey ^b   Zamis, Lindsay ^a   Demeester, Tom ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF PERADENIYA   (Sri Lanka)

Author keywords

Barrett esophagus; biopsy; columnar lined esophagus; esophageal adenocarcinoma; intestinal metaplasia

Indexed keywords

ADENOCARCINOMA; ARTICLE; CARDIA; EPITHELIUM; ESOPHAGUS; ESOPHAGUS TUMOR; HUMAN; INTESTINE; METAPLASIA; PATHOLOGY; PRECANCER; RISK FACTOR;

ADENOCARCINOMA; CARDIA; EPITHELIUM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; INTESTINES; METAPLASIA; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 84355162994     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31822a5a2c     Document Type: Article

References (35)

1. Allison PR, Johnstone AS. The oesophagus lined with gastric mucous membrane. Thorax. 1953;8:87-101.
2. Barrett NR. The lower esophagus lined by columnar epithelium. Surgery. 1957;41:881-894.
3. British Society of Gastroenterology Guidelines for the diagnosis and management of Barrett's columnar lined oesophagus. A report of the working party of the British Society of Gastroenterology. http://www.bsg.org.uk.
4. Cameron AJ, Lomboy CT, Pera M, et al. Adenocarcinoma of the esophago-gastric junction and Barrett's esophagus. Gastroenterol-ogy. 1995;109:1541-1546.
5. Chandrasoma P. Controversies of the cardiac mucosa and Barrett's esophagus. Histopathol. 2005;46:361-373. (Pubitemid 40516751)
6. Chandrasoma PT, Der R, Dalton P, et al. Distribution and significance of epithelial types in columnar lined esophagus. Am J Surg Pathol. 2001;25:1188-1193. (Pubitemid 32777719)
7. Chandrasoma PT, Der R, Ma Y, et al. Histologic classification of patients based on mapping biopsies of the gastroesophageal junction. Am J Surg Pathol. 2003;27:929-936. (Pubitemid 36758896)
8. Chandrasoma PT, Wickramasinghe K, Ma Y, et al. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia? Dis Esophagus. 2007;20:36-41. (Pubitemid 46099873)
9. Chandrasoma PT, Wijetunge S, DeMeester SR, et al. The histologic squamo-oxyntic gap: an accurate and reproducible diagnostic marker of gastroesophageal reflux disease. Am J Surg Pathol. 2010;34:1574-1581.
10. Corley DA, Levin TR, Habel LA, et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenter-ology. 2002;122:633-640. (Pubitemid 34173814)
11. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049-2053. (Pubitemid 28525384)
12. Flejou J-F, Odze RD, Montgomery E, et al. Adenocarcinoma of the Esophagus. In: Bosman FT, Carneiro F, Hruban RH, et al, eds. WHO Classification of Tumours of the Digestive System. 4th ed. World Health Organization: Lyon; 2010:25-31.
13. Gatenby PA, Ramus JR, Caygill CP, et al. Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined oesophagus. Scand J Gastroenterol. 2008;43:524-530. (Pubitemid 351536041)
14. Haggitt RC, Dean PJ. Adenocarcinoma in Barrett's epithelium. In: Spechler SJ, Goyal RK, eds. Barrett's Esophagus: Pathophysiology, Diagnosis and Management. New York: Elsevier Science Publishing; 1985:153-166.
15. Hayward J. The lower end of the oesophagus. Thorax. 1961;16:36-41.
16. Kelty C, Gough M, van Wyk Q. Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk. Scand J Gastroenterol. 2007;42:1271-1274. (Pubitemid 47537076)
17. Liu W, Hahn H, Odze RD, et al. Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol. 2009;104:816-824.
18. Murray L, Watson P, Johnston B, et al. Risk of adenocarcinoma in Barrett's oesophagus: population-based study. Brit Med J. 2003;327:534-535. (Pubitemid 37088499)
19. Paraf F, Flejou JF, Pignon JP, et al. Surgical pathology of adenocarcinoma arising in Barrett's esophagus: analysis of 67 cases. Am J Surg Pathol. 1995;19:183-191.
20. Paull A, Trier JS, Dalton MD, et al. The histologic spectrum of Barrett's esophagus. N Eng J Med. 1976;295:476-480.
21. Peters JH, Clark GWB, Ireland AP, et al. Outcome of adenocarci-noma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg. 1994;108:813-821.
22. Peyre CG, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248:549-556.
23. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142-146. (Pubitemid 40277094)
24. Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125:1670-1677. (Pubitemid 37500431)
25. Riddell RH, Odze RD. Definition of Barrett's esophagus: time for a rethink: is intestinal metaplasia dead? Am J Gastroenterol. 2009;104:2588-2594.
26. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastro-enterology. 2005;129:1825-1831. (Pubitemid 41772961)
27. Rosenberg JC, Budev H, Edwards RC, et al. Analysis of adenocarcinoma in Barrett's esophagus utilizing a staging system. Cancer. 1985;55:1353-1360. (Pubitemid 15143415)
28. Ruol A, Parent A, Zaninotto G, et al. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia. Cancer. 2000;88:2520-2528. (Pubitemid 30331958)
29. Skinner DB, Walther BC, Riddell RH, et al. Barrett's esophagus: comparison of benign and malignant cases. Ann Surg. 1983;198: 554-565.
30. Spechler SJ, Sharma P, Souza RF, et al. American Gastroenter-ological Association Medical Position Statement on the Management of Barrett's esophagus. Gastroenterology. 2011;140: 1084-1091.
31. Takubo K, Aida J, Naomoto Y, et al. Cardiac rather than intestinal-type background in endoscopic mucosal resection specimens of minute Barrett adenocarcinoma. Hum Pathol. 2009;40:65-74.
32. Tharavej C, Hagen JA, Peters JH, et al. Predictive factors of coexisting cancer in Barrett's high grade dysplasia. Surg Endosc. 2006;20:439-443. (Pubitemid 43260503)
33. Theisen J, Stein HJ, Dittler HJ, et al. Preoperative chemotherapy unmasks underlying Barrett's mucosa in patients with adenocarci-noma of the distal esophagus. Surg Endosc. 2002;16:671-673. (Pubitemid 34263435)
34. van Sandyck JW, van Lanschot JJ, ten Kate FJ, et al. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer. 2000;88:2429-2437. (Pubitemid 30331946)
35. Wijetunge S, Ma YL, DeMeester SR, et al. Association of adenocarcinomas of the distal esophagus, "gastroesophageal junction" and "gastric cardia" with gastric pathology. Am J Surg Pathol. 2010;34:1521-1527.